Improved 1‐Year Clinical Success Rate of Pulmonary Vein Isolation with the Second‐Generation Cryoballoon in Patients with Paroxysmal Atrial Fibrillation

Publisher： John Wiley & Sons Inc

E-ISSN： 1540-8167|25|8|840-844

ISSN： 1045-3873

Source： JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol.25, Iss.8, 2014-08, pp. : 840-844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Improved Efficacy of Second‐Generation Cryoballoon

BackgroundThe second‐generation cryoballoon (CB2) has recently been introduced featuring improved surface cooling. Increased procedural efficacy of pulmonary vein isolation (PVI) when compared to the first‐generation balloon (CB1) has been reported. The aim of the study was to investigate the clinical outcome of cryoballoon PVI after 1 year using the CB2 as compared to the CB1.
Methods and ResultsA total of 105 consecutive patients with paroxysmal atrial fibrillation (AF) were studied. Cryoballoon PVI (28 mm) was performed in 50 patients using the CB1, and in 55 patients using the CB2. Patients were scheduled for 72‐hour Holter ECG recording at 3, 6, 9, and 12 months and every 6 months thereafter. The study endpoint was defined as recurrent AF or atrial tachycardia >30 seconds documented after a blanking period of 90 days after the procedure. Complete PVI was achieved in 49/50 (98%) and 55/55 (100%) patients in the CB1 and CB2 group, respectively. After a mean follow‐up of 416 ± 75 days, 21 (CB1 group) and 10 (CB2 group) patients reached the study endpoint. Kaplan–Meier estimates of arrhythmia‐free survival after a single procedure without AAD therapy after 1 year were 63.9% versus 83.6% (P = 0.008) in the CB1 and CB2 group, respectively. Persistent phrenic nerve palsy with delayed healing occurred in 2 (CB1 group) and 3 (CB2 group) patients.
ConclusionClinical outcome of PVI using the CB2 was significantly improved when compared to the CB1.

Related content

Cardiac Autoantibody Levels Predict Recurrence Following Cryoballoon‐Based Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Patients

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 6, 2015-06 ,pp. : 615-621 (7)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ablation of paroxysmal atrial fibrillation using a second‐generation cryoballoon catheter or contact‐force sensing radiofrequency ablation catheter: A comparison of costs and long‐term clinical outcomes

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 29, Iss. 2, 2018-02 ,pp. : 284-290 (7)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary vein isolation with real‐time pulmonary vein potential recording using second‐generation cryoballoon: Procedural and biophysical predictors of acute pulmonary vein reconnection

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 41, Iss. 1, 2018-01 ,pp. : 14-21 (8)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second‐generation cryoballoon ablation for treatment of persistent atrial fibrillation: Three‐year outcome and predictors of recurrence after a single procedure

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 29, Iss. 1, 2018-01 ,pp. : 38-45 (8)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact on Clinical Outcome of Premature Interruption of Cryoenergy Delivery Due to Phrenic Nerve Palsy During Second Generation Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 9, 2015-09 ,pp. : 950-955 (6)

John Wiley & Sons Inc

Access to resources Recommend Favorite